[1] |
Carroli G, Cuesta C, Abalos E, et al. Epidemiology of postpartum haemorrhage: a systematic review[J]. Best Pract Res Clin Obstet Gynaecol, 2008, 22(6):999-1012.
|
[2] |
Wedisinghe L, Macleod M, Murphy DJ. Use of oxytocin to prevent haemorrhage at caesarean section--a survey of practice in the United Kingdom[J]. Eur J Obstet Gynecol Reprod Biol, 2008, 137(1):27-30.
|
[3] |
Stafford I, Dildy GA, Clark SL, et al. Visually estimated and calculated blood loss in vaginal and cesarean delivery[J]. Am J Obstet Gynecol, 2008, 199(5):519.e1-e7.
|
[4] |
World Health Organization. WHO recommendations for the prevention and treatment of postpartum haemorrhage[R]. Geneva: World Health Organization, 2012.
|
[5] |
Bais JM, Eskes M, Pel M, et al. Postpartum haemorrhage in nulliparous women: incidence and risk factors in low and high risk women. A Dutch population-based cohort study on standard (> or = 500 ml) and severe (> or = 1000 ml) postpartum haemorrhage[J]. Eur J Obstet Gynecol Reprod Biol, 2004, 115(2):166-172.
|
[6] |
Zubor P, Kajo K, Dokus K, et al. Recurrent secondary postpartum hemorrhages due to placental site vessel subinvolution and local uterine tissue coagulopathy[J]. BMC Pregnancy Childbirth, 2014, 14:80.
|
[7] |
Driessen M, Bouvier-Colle MH, Dupont C, et al. Postpartum hemorrhage resulting fromuterine atony after vaginal delivery: factors associated with severity[J]. Obstet Gynecol, 2011, 117(1):21-31.
|
[8] |
Gizzo S, Patrelli TS, Gangi SD, et al. Which uterotonic is better to prevent the postpartum hemorrhage? Latest news in terms of clinical efficacy, side effects, and contraindications: a systematic review[J]. Reprod Sci, 2013, 20(9):1011-1109.
|
[9] |
Shields LE, Smalarz K, Reffigee L, et al. Comprehensive maternal hemorrhage protocols improve patient safety and reduce utilization of blood products[J]. Am J Obstet Gynecol, 2011, 205(4):368.e1-e8.
|
[10] |
Chen M, Chang Q, Duan T, et al. Uterine massage to reduce blood loss after vaginal delivery:a randomized controlled trial[J]. Obstet Gynecol, 2013, 122(2 Pt 1):290-295.
|
[11] |
Sloan NL, Durocher J, Aldrich T, et al. What measured blood loss tells us about postpartum bleeding:a systematic review[J]. BJOG, 2010, 117(7):788-800.
|
[12] |
中华医学会妇产科学分会产科学组. 产后出血预防与处理指南(2014)[J]. 中华妇产科杂志,2014, 49(9):641-646.
|
[13] |
Sheldon WR, Blum J, Durocher J, et al. Misoprostol for the prevention and treatment of postpartum hemorrhage[J]. Expert Opin Investig Drugs, 2012, 21(2):235-250.
|
[14] |
Buttino L Jr, Garite TJ. The use of 15 methyl F2 alpha prostaglandin (Prostin 15M) for the control of postpartum hemorrhage[J]. Am J Perinatol, 1986, 3(3):241-243.
|
[15] |
Waters EG. Surgical management of postpartum hemorrhage with particular reference to ligation of uterine arteries[J]. Am J Obstet Gynecol, 1952, 64(5): 1143-1148.
|
[16] |
O′Leary JA. Uterine artery ligation in the control of postcesarean hemorrhage[J]. J Reprod Med, 1995, 40(3):189-193.
|
[17] |
Kaya B, Tuten A, Daglar K, et al. B-Lynch uterine compression sutures in the conservative surgical management of uterine atony[J]. Arch Gynecol Obstet, 2014 Oct 15. [Epub ahead of print]
|
[18] |
Cheong JY, Kong TW, Son JH, et al. Outcome of pelvic arterial embolization for postpartum hemorrhage: A retrospective review of 117 cases[J]. Obstet Gynecol Sci, 2014, 57(1):17-27.
|
[19] |
Flood KM, Said S, Geary M, et al. Changing trends in peripartum hysterectomy over the last 4 decades[J]. Am J Obstet Gynecol, 2009, 200(6):632.e1-e6.
|
[20] |
Persson P, Brynhildsen J, Kjølhede P, et al. Pelvic organ prolapse after subtotal and total hysterectomy: a long-term follow-up of an open randomised controlled multicentre study[J]. BJOG, 2013, 120(12):1556-1565.
|